Glory Holdings reported on December 13 that Haobo (688656.SH) announced that, according to the "Transfer Registration Confirmation" issued by China Securities Depository and Clearing Corporation Limited on December 13, 2024, the transfer registration procedures for this share transfer have been completed, with the transfer date being December 12, 2024. The number of shares transferred is 18,670,878 shares, accounting for 29.99% of the total shares of Haobo after deducting the shares in the repurchase special account, and the nature of the shares is unrestricted tradable shares. After the completion of this share transfer and the renunciation of voting rights, Huiguang Runkang holds 18,670,878 shares in the company and the corresponding voting rights, accounting for 29.99% of the total shares of Haobo after deducting the shares in the repurchase special account. The original actual controllers of Haobo, JOHNLI, WEIJUNLI, and Chen Tao, through Hai Rui Xiang Tian, Suzhou Wai Run, and direct shareholding, collectively control 16.17% of the voting rights of Haobo after deducting the shares in the repurchase special account. The company's controlling shareholder has changed from Hai Rui Xiang Tian to Huiguang Runkang, and the actual controllers of the company have changed from JOHNLI, WEIJUNLI, and Chen Tao to SINO BIOPHARM.